
Corteva Plans Strategic Split as 2025 Operating EBITDA Climbs to $3.8 Billion
Corteva, Inc.Description
What this story covers
Noah and Ash discuss Corteva's twenty twenty five performance, highlighting a 3 percent sales increase and a major planned business separation. They explore how R&D in gene editing and operational restructuring are driving profitability despite global agricultural and regulatory risks.
Story snapshot
CompanyCorteva, Inc.
TickerCTVA
VariantStandard detailed
Duration11:45
Filing type10-K
PeriodAnnual 2025
IndustryAgriculture
Accession0001755672-26-000004
Sources1
Full Story Script
Content not available for this story.